Cargando…

Recombinant Modified Vaccinia Virus Ankara (MVA) Vaccines Efficiently Protect Cockatiels Against Parrot Bornavirus Infection and Proventricular Dilatation Disease

Parrot bornaviruses (PaBVs) are the causative agents of proventricular dilatation disease (PDD), a chronic and often fatal neurologic disorder in Psittaciformes. The disease is widely distributed in private parrot collections and threatens breeding populations of endangered species. Thus, immunoprop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rall, Isabell, Amann, Ralf, Malberg, Sara, Herden, Christiane, Rubbenstroth, Dennis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6950018/ https://www.ncbi.nlm.nih.gov/pubmed/31817690 http://dx.doi.org/10.3390/v11121130

Ejemplares similares

Tissue Distribution of Parrot Bornavirus 4 (PaBV-4) in Experimentally Infected Young and Adult Cockatiels (Nymphicus hollandicus)
por: Petzold, Jana, et al.
Publicado: (2022)

Viral vector vaccines expressing nucleoprotein and phosphoprotein genes of avian bornaviruses ameliorate homologous challenge infections in cockatiels and common canaries
por: Olbert, Marita, et al.
Publicado: (2016)

Experimental induction of proventricular dilatation disease in cockatiels (Nymphicus hollandicus) inoculated with brain homogenates containing avian bornavirus 4
por: Gancz, Ady Y, et al.
Publicado: (2009)

Experimental Infection of Embryonic Cells and Embryonated Eggs of Cockatiels (Nymphicus hollandicus) with Two Parrot Bornavirus Isolates (PaBV-4 and PaBV-2)
por: Wuest, Elisa, et al.
Publicado: (2022)

Apparent resolution of parrot bornavirus infection in cockatiels (Nymphicus hollandicus)
por: Murray, Olivia, et al.
Publicado: (2017)

Pathogenesis of Avian Bornavirus in Experimentally Infected Cockatiels
por: Piepenbring, Anne K., et al.
Publicado: (2012)

Avian Bornaviruses in Psittacine Birds from Europe and Australia with Proventricular Dilatation Disease
por: Weissenböck, Herbert, et al.
Publicado: (2009)

Use of Avian Bornavirus Isolates to Induce Proventricular Dilatation Disease in Conures
por: Gray, Patricia, et al.
Publicado: (2010)

The Isolation, Pathogenesis, Diagnosis, Transmission, and Control of Avian Bornavirus and Proventricular Dilatation Disease
por: Hoppes, Sharman, et al.
Publicado: (2010)

Treatment With Nonsteroidal Anti-Inflammatory Drugs Fails To Ameliorate Pathology In Cockatiels Experimentally Infected With Parrot Bornavirus-2
por: Escandon, Paulina, et al.
Publicado: (2019)

Recovery of divergent avian bornaviruses from cases of proventricular dilatation disease: Identification of a candidate etiologic agent
por: Kistler, Amy L, et al.
Publicado: (2008)

Factors Influencing Vertical Transmission of Psittacine Bornavirus in Cockatiels (Nymphicus hollandicus)
por: Link, Jessica, et al.
Publicado: (2022)

From nerves to brain to gastrointestinal tract: A time-based study of parrot bornavirus 2 (PaBV-2) pathogenesis in cockatiels (Nymphicus hollandicus)
por: Leal de Araujo, Jeann, et al.
Publicado: (2017)

Parrot bornavirus in naturally infected Brazilian captive parrots: Challenges in viral spread control
por: Silva, Aila Solimar Gonçalves, et al.
Publicado: (2020)

Recombination-Mediated Genetic Engineering of a Bacterial Artificial Chromosome Clone of Modified Vaccinia virus Ankara (MVA)
por: Cottingham, Matthew G., et al.
Publicado: (2008)

Ribavirin Inhibits Parrot Bornavirus 4 Replication in Cell Culture
por: Musser, Jeffrey M. B., et al.
Publicado: (2015)

Correction: Recombination-Mediated Genetic Engineering of a Bacterial Artificial Chromosome Clone of Modified Vaccinia virus Ankara (MVA)
por: Cottingham, Matthew G., et al.
Publicado: (2011)

Campylobacter colonization is not associated with proventricular dilatation disease in psittacines
por: Bulbow, Holden, et al.
Publicado: (2017)

A Genotype of Modified Vaccinia Ankara (MVA) that Facilitates Replication in Suspension Cultures in Chemically Defined Medium
por: Jordan, Ingo, et al.
Publicado: (2013)

Environmental Risk Assessment of Clinical Trials Involving Modified Vaccinia Virus Ankara (MVA)-Based Vectors
por: Goossens, Martine, et al.
Publicado: (2013)

Genome Sequencing of a Camelpox Vaccine Reveals Close Similarity to Modified Vaccinia virus Ankara (MVA)
por: Marcacci, Maurilia, et al.
Publicado: (2020)

Diversity of cell death signaling pathways in macrophages upon infection with modified vaccinia virus Ankara (MVA)
por: Klaas, Lioba, et al.
Publicado: (2021)

Avian Bornavirus Research—A Comprehensive Review
por: Rubbenstroth, Dennis
Publicado: (2022)

Induction of Antibody Responses to African Horse Sickness Virus (AHSV) in Ponies after Vaccination with Recombinant Modified Vaccinia Ankara (MVA)
por: Chiam, Rachael, et al.
Publicado: (2009)

Evaluation of the efficacy of modified vaccinia Ankara (MVA)/IMVAMUNE(®) against aerosolized rabbitpox virus in a rabbit model()
por: Garza, Nicole L., et al.
Publicado: (2009)

Modified Vaccinia Virus Ankara (MVA) as Production Platform for Vaccines against Influenza and Other Viral Respiratory Diseases
por: Altenburg, Arwen F., et al.
Publicado: (2014)

Novel Borna Virus in Psittacine Birds with Proventricular Dilatation Disease
por: Honkavuori, Kirsi S., et al.
Publicado: (2008)

Are anti-ganglioside antibodies associated with proventricular dilatation disease in birds?
por: Leal de Araujo, Jeann, et al.
Publicado: (2017)

Advanced Diagnostic Approaches and Current Management of Proventricular Dilatation Disease
por: Gancz, Ady Y., et al.
Publicado: (2010)

Comparison of lyophilized versus liquid modified vaccinia Ankara (MVA) formulations and subcutaneous versus intradermal routes of administration in healthy vaccinia-naïve subjects
por: Frey, Sharon E., et al.
Publicado: (2015)

Vertical Transmission of Avian Bornavirus in Psittacines
por: Lierz, Michael, et al.
Publicado: (2011)

Recombinant Modified Vaccinia Virus Ankara (MVA) Expressing Wild-Type Human p53 Induces Specific Antitumor CTL Expansion
por: Song, Guang-Yun, et al.
Publicado: (2011)

Phase I Safety and Immunogenicity Evaluation of MVA-CMDR, a Multigenic, Recombinant Modified Vaccinia Ankara-HIV-1 Vaccine Candidate
por: Currier, Jeffrey R., et al.
Publicado: (2010)

Immunogenicity and Safety of Modified Vaccinia Ankara (MVA) Vaccine—A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Nave, Lior, et al.
Publicado: (2023)

Two novel bornaviruses identified in colubrid and viperid snakes
por: Pfaff, Florian, et al.
Publicado: (2021)

Human bornavirus research: Back on track!
por: Rubbenstroth, Dennis, et al.
Publicado: (2019)

HIV-1 gp120 and Modified Vaccinia Virus Ankara (MVA) gp140 Boost Immunogens Increase Immunogenicity of a DNA/MVA HIV-1 Vaccine
por: Shen, Xiaoying, et al.
Publicado: (2017)

Seeing beyond a Dilated Proventriculus: Diagnostic Tools for Proventricular Dilatation Disease in Psittacine Birds
por: Leal de Araújo, Jeann, et al.
Publicado: (2021)

Zinc-finger antiviral protein (ZAP) is a restriction factor for replication of modified vaccinia virus Ankara (MVA) in human cells
por: Peng, Chen, et al.
Publicado: (2020)

Alphavirus Replicon DNA Expressing HIV Antigens Is an Excellent Prime for Boosting with Recombinant Modified Vaccinia Ankara (MVA) or with HIV gp140 Protein Antigen
por: Knudsen, Maria L., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qp5rub7ceo53cncqlmf4snh5si